Advertisement
UK markets open in 1 hour 22 minutes
  • NIKKEI 225

    38,748.63
    +512.56 (+1.34%)
     
  • HANG SENG

    18,454.25
    -124.05 (-0.67%)
     
  • CRUDE OIL

    78.60
    +0.12 (+0.15%)
     
  • GOLD FUTURES

    2,330.20
    -1.00 (-0.04%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • Bitcoin GBP

    50,403.22
    -753.45 (-1.47%)
     
  • CMC Crypto 200

    1,364.52
    +51.90 (+3.96%)
     
  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     
  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

Why Did Invitae Stock Fall 17% in July?

Why Did Invitae Stock Fall 17% in July?

Invitae (NYSE: NVTA) shares dropped 17% in July as investors moved capital away from the smaller innovative genomic science stocks. No meaningful news was published about the stock, though there were announcements that other care providers would be partnering with Invitae to add genetic testing to their service selection. Invitae is a relatively small and unprofitable company with massive growth aspirations.